About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch

Biovault Technical

About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch
25 June 2026
Cellular Therapies, Quality & Safety
Sarah Conway
What happens after a stem cell donor says yes

Explore the zero-margin-for-error custody chain in PBSC processing. Learn how Biovault Technical meets HTA and JACIE standards to ensure transplant viability.

What happens after a stem cell donor says yes
19 May 2026
Cellular Therapies, Innovation
Sarah Conway
Beyond Oncology: The landmark cellular therapy ...

To mark Clinical Trials Day, we explore 5 landmark international trials redefining cellular therapy. From record-breaking oncology survival data to functional cures for severe autoimmunity and HIV, discover the breakthroughs transforming medicine from the lab to the bedside.

Beyond Oncology: The landmark cellular therapy trials redefining modern medicine
6 May 2026
Quality & Safety, Regulatory Partnerships, Cellular Therapies, Innovation, Ethical Practices
Sarah Conway
Donor lymphocyte infusions: from reactive ...

Donor lymphocyte infusions (DLI) and clinical readiness. Discover Biovault’s pre-prepared DLI processing and storage approach for faster access and reduced risk.

Donor lymphocyte infusions: from reactive intervention to clinical readiness
30 March 2026
Industry Events, Company News, Cellular Therapies
Sarah Conway
EBMT 2026: 5 Insights Shaping the Future of ...

5 key takeaways from EBMT 2026, from expanded cord blood and JACIE quality to regulation, infrastructure and the future of cell therapy.

EBMT 2026: 5 Insights Shaping the Future of Cell Therapy
10 February 2026
Cellular Therapies, Innovation
Sarah Conway
The Evolution of Cell Therapy Part 3: Immune ...

Explore how PBSCs enabled CAR-T and immune effector cell therapies, and how Biovault supports safe processing, storage and delivery of advanced cellular medicines.

The Evolution of Cell Therapy Part 3: Immune Effector Cell Therapies
Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources

Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources
Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

The UK healthcare sector produces hundreds of thousands of tonnes of waste every year. At Biovault, we’re working to reduce waste in every area and have been inspired by the difference it makes.

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies

EBMT Round up: 5 Key Takeaways from Glasgow 2024

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies
EBMT Round up: 5 Key Takeaways from Glasgow 2024

EBMT 2024 was an inspiring event combining a patient-first ethos with insights from cellular therapy pioneers. We share our Top 5 Takeaways.

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships

Preventing catastrophic failure in biobank systems

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships
Preventing catastrophic failure in biobank systems

Following the publication of a report on the devastating cryogenic freezer failure at the Karolinska Institutet (KI) in Sweden in December 2023, we scrutinise our systems and offer some support. 

Sarah Conway
13 March 2024
Cellular Therapies, Quality & Safety, Company News

Elevating Patient Care: Biovault's Expertise in Peripheral Blood Stem Cell (PBSC) Solutions

Sarah Conway
13 March 2024
Cellular Therapies, Quality & Safety, Company News
Elevating Patient Care: Biovault's Expertise in Peripheral Blood Stem Cell (PBSC) Solutions

In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.

Sarah Conway
10 February 2024
Company News, Ethical Practices

Women and Girls in (biomedical) Science

Sarah Conway
10 February 2024
Company News, Ethical Practices
Women and Girls in (biomedical) Science

Everyone should have full and equal access to science education and careers, but do they? February 11th is the United Nations International Day of Women and Girls in Science. We check up on equality of access in the UK and at Biovault.

Sarah Conway
18 December 2023
Company News

Looking ahead to 2024

Sarah Conway
18 December 2023
Company News
Looking ahead to 2024

As 2023 draws to a close, we look ahead to three innovations set to transform the way we serve our community, clients and ecosystem in 2024.

Newer Posts
Older Posts
Back to Top
Biovault Technical Ltd, Plymouth International Medical & Technology Park, 24 Brest Road, Derriford, Plymouth, PL6 5XP, United Kingdom+44 1752 753720info@biovaulttechnical.co.uk

address

Biovault Technical
24 Brest Road
Plymouth, PL6 5XP
View on map

TELEPHONE

+44 (0)1752 753720

enquiries

info@biovaulttechnical.co.uk

careers

COOKIE POLICY

Privacy Policy

CONTACT